No Data
No Data
No Data
Lexagene Holdings Inc. Brief: Up 21% Early Friday As BioPharma Engages It in Second Feasibility Study; LXG Cancels Plans to Reprice Meridian's Warrants
09:37 AM EST, 12/16/2022 (MT Newswires) -- Price: 0.17, Change: +0.03, Percent Change: +21.43
LexaGene Holdings Inc. (OTCMKTS:LXXGF) Sees Large Drop in Short Interest
LexaGene Holdings Inc. (OTCMKTS:LXXGF – Get Rating) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totalling 99,700 shares, a decre
LexaGene Holdings Inc. (OTCMKTS:LXXGF) Sees Significant Decline in Short Interest
LexaGene Holdings Inc. (OTCMKTS:LXXGF – Get Rating) saw a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 99,700 shares, a decrea
Short Interest in LexaGene Holdings Inc. (OTCMKTS:LXXGF) Drops By 83.3%
LexaGene Holdings Inc. (OTCMKTS:LXXGF – Get Rating) saw a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 22,600 shares, a decrease
LexaGene Holdings Inc. (OTCMKTS:LXXGF) Sees Large Increase in Short Interest
LexaGene Holdings Inc. (OTCMKTS:LXXGF – Get Rating) was the target of a significant increase in short interest in May. As of May 31st, there was short interest totalling 70,700 shares, an increase of
LexaGene Holdings Inc. (OTCMKTS:LXXGF) Short Interest Update
LexaGene Holdings Inc. (OTCMKTS:LXXGF – Get Rating) was the target of a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 22,400 shares, a